← Leaderboards
David S Chia
University Of California Los Angeles
$9,399,833
Attributed
$10,892,480
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,892,480 · 6
By mechanism
U24$7,307,439 · 1
N01$1,592,919 · 2
UH3$1,158,300 · 1
R21$465,376 · 1
UH2$368,446 · 1
Top collaborators
- David T Wong7 shared
- Guy Soo Hoo5 shared
- Fang Wei5 shared
- Kingshuk Das2 shared
- R Hal Scofield2 shared
- Charles Martin Strom1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- David T Wong$54,826,713
- Jerome A. Zack$38,514,975
- Lashonda Spencer$0
- Judith S. Currier$525,401,794
- Guy Soo Hoo$344,349
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionHuman ResourcesLaboratoriesLiquid SubstanceResourcesTissuesMalignant Neoplasm Of LungBiomarkerDiagnosisCostClinical ResearchMemberMolecular ProfilingMissionEarly Detection Research NetworkMalignant Neoplasm Of ProstateNucleic AcidsLeadershipDensityComprehensive Cancer CenterCollaborationsDesignDna Modification ProcessFunding
Grant awards (25)
Saliva Anti-SSA/Ro and Anti-SSB/La for Early Detection of Sjögrenâs and SICCA Syndromes$205,001
R21 · FY2025 · DE
Saliva Anti-SSA/Ro and Anti-SSB/La for Early Detection of Sjögrenâs and SICCA Syndromes$260,375
R21 · FY2024 · DE
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients$390,000
UH3 · FY2021 · CA
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients$390,000
UH3 · FY2020 · CA
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients$378,300
UH3 · FY2019 · CA
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients$184,223
UH2 · FY2018 · CA
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients$184,223
UH2 · FY2017 · CA
The Early Detection Research Network Biomarker Resource Laboratory at UCLA$369,494
U24 · FY2014 · CA · contact PI
The Early Detection Research Network Biomarker Resource Laboratory at UCLA$358,065
U24 · FY2013 · CA · contact PI
The Early Detection Research Network Biomarker Resource Laboratory at UCLA$379,129
U24 · FY2012 · CA · contact PI
The Early Detection Research Network Biomarker Resource Laboratory at UCLA$380,921
U24 · FY2011 · CA · contact PI
The Early Detection Research Network Biomarker Resource Laboratory at UCLA$392,700
U24 · FY2010 · CA · contact PI
The Early Detection Research Network: Biomarker Referen*$154,000
U24 · FY2010 · CA · contact PI
The Early Detection Research Network: Biomarker Referen*$459,897
U24 · FY2009 · CA · contact PI
The Early Detection Research Network: Biomarker Referen*$473,491
U24 · FY2008 · CA · contact PI
PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER SCREENING TRIAL - LABORA$1,008,581
N01 · FY2007 · CA · contact PI
The Early Detection Research Network: Biomarker Referen*$474,500
U24 · FY2007 · CA · contact PI
The Early Detection Research Network: Biomarker Referen*$133,316
U24 · FY2006 · CA · contact PI
The Early Detection Research Network: Biomarker Referen*$613,916
U24 · FY2005 · CA
BIOMARKERS VALIDATION LABORATORIES$736,236
U24 · FY2004 · CA
BIOMARKERS VALIDATION LABORATORIES$714,899
U24 · FY2003 · CA
BIOMARKERS VALIDATION LABORATORIES$694,835
U24 · FY2002 · CA
BIOMARKERS VALIDATION LABORATORIES$676,070
U24 · FY2001 · CA
PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER$584,338
N01 · FY2000 · CN
BIOMARKERS VALIDATION LABORATORIES$295,970
U24 · FY2000 · CA